BiotechTube

Vancomycin + Linezolid

ApprovedCompleted
1 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Pneumonia, Ventilator-Associated

Conditions

Pneumonia, Ventilator-Associated

Trial Timeline

Nov 1, 2002 → Jan 1, 2005

NCT ID
NCT00572559

About Vancomycin + Linezolid

Vancomycin + Linezolid is a approved stage product being developed by Pfizer for Pneumonia, Ventilator-Associated. The current trial status is completed. This product is registered under clinical trial identifier NCT00572559. Target conditions include Pneumonia, Ventilator-Associated.

What happened to similar drugs?

19 of 20 similar drugs in Pneumonia, Ventilator-Associated were approved

Approved (19) Terminated (4) Active (1)
✅doripenemJohnson & JohnsonApproved
✅Simultaneous administration of Pneumovax NP® and Fluvic HA syringe® + Sequential administration of Pneumovax NP® and Fluvic HA syringe®MerckApproved
✅Imipenem + ImipenemMerckApproved
✅Ceftolozane / Tazobactam InjectionMerckApproved
✅ceftriaxoneRocheApproved
✅Zavicefta, Ceftazidime-AvibactamPfizerApproved
✅Azithromycin + Ampicillin/sulbactamPfizerApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00572559ApprovedCompleted

Competing Products

20 competing products in Pneumonia, Ventilator-Associated

See all competitors
ProductCompanyStageHype Score
CAL02 Low-dose + CAL02 High-dose + PlaceboCombioxinPhase 1
19
tacrolimusAstellas PharmaPre-clinical
26
Cefiderocol + Best Available TherapyShionogiPhase 3
40
Cefiderocol + Meropenem + LinezolidShionogiPhase 3
40
Cefiderocol + Standard of Care AntibioticShionogiPhase 1
21
ONO-5046Na + ONO-5046NaOno PharmaceuticalPhase 2
35
doripenemJohnson & JohnsonApproved
43
levofloxacin; imipenem/cilastitinJohnson & JohnsonPhase 3
40
levofloxacinJohnson & JohnsonPhase 3
40
levofloxacinJohnson & JohnsonPhase 2/3
38
LevofloxacinJohnson & JohnsonPhase 3
40
doripenemJohnson & JohnsonPhase 3
40
doripenemJohnson & JohnsonPhase 3
40
Doripenem + Imipenem-Cilastatin + PlaceboJohnson & JohnsonPhase 3
32
Imipenem/cilastatin + Imipenem/cilastatin + Doripenem + DoripenemJohnson & JohnsonPhase 2
35
HRS-8427 + MeropenemJiangsu Hengrui MedicinePhase 2
42
Ceftazidime-avibactamAbbViePhase 1
21
Ticagrelor + PlaceboAstraZenecaPhase 2
27
Tedizolid phosphate + LinezolidMerckPhase 3
40
Ceftolozane/Tazobactam + Piperacillin/TazobactamMerckPhase 3
32